David M. O’Malley - Publications, H-index & Citations

David M. O’Malley

the ohio state university comprehensive cancer center-james cancer hospital and solove research institute

88H指数

884论文数

3.1W被引数

收录论文 122

发表时间

Immunotherapy-induced thyroid dysfunction and diabetes mellitus in gynecologic oncology patients: a retrospective cohort study 免疫疗法诱导的甲状腺功能障碍和糖尿病在妇科肿瘤患者中的发生：一项回顾性队列研究

Gynecologic Oncology

IF4.1

2026-09-22

OAAI

Anna Gonzalez; Julia Chalif; Reed O'Connor; Eric McLaughlin; Molly Morton; Jessica Fulton; Jessica Velasquez; David E. Cohn; Casey M. Cosgrove; Larry J. Copeland; Christa I. Nagel; Floor Backes; David M. O'Malley; Laura M. Chambers

Correction: Obesity-induced extracellular vesicles proteins drive the endometrial cancer pathogenesis: therapeutic potential of HO-3867 and Metformin 更正：肥胖诱导的细胞外囊泡蛋白驱动子宫内膜癌的发生：HO-3867和二甲双胍的潜在治疗作用

Oncogene

IF7.3

2026-08-03

OAAI

Takahiko Sakaue; Kalpana Deepa Priya Dorayappan; Roman Zingarelli; Wafa Khadraoui; Muralidharan Anbalagan; John Wallbillich; Balazs Bognar; Ross Wanner; Casey Cosgrove; Adrian Suarez; Hironori Koga; G. Larry Maxwell; David M. O’Malley; David E. Cohn; Karuppaiyah Selvendiran

Serum Extracellular Vesicle Protein Signatures Associated with Early-Stage High-Grade Serous Ovarian Carcinoma 血清外泌体蛋白特征与早期高级别浆液性卵巢癌的相关性

Cells

IF5.2

2026-04-17

OAAI

Michelle Lightfoot; Kalpana Deepa Priya Dorayappan; Vignesh Vudatha; Lakshmi Narasimhan. Chakrapani; Priyam Das; Lianbo Yu; Colin Hisey; Takahiko Sakaue; Thangavel Muthusamy; Parthiban Panneerselvam; Floor Backes; Casey Cosgrove; Derek Hansford; David E. Cohn; David M. O’Malley; Rajan Gogna; Karuppaiyah Selvendiran

The combination of avutometinib and defactinib in treating recurrent low-grade serous ovarian cancer: a plain language summary of the Phase II clinical trial ENGOT-OV60/GOG-3052/RAMP 201 阿伐木单抗与德法他尼联用治疗复发性低级别浆液性卵巢癌：ENGOT-OV60/GOG-3052/RAMP 201 II期临床试验的通俗语言总结

Future Oncology

IF2.6

2025-12-12

OAAI

Susana N. Banerjee; Els Van Nieuwenhuysen; Carol Aghajanian; Véronique D’Hondt; Bradley J. Monk; Andrew Clamp; Emily Prendergast; Ana Oaknin; Kari Ring; Nicoletta Colombo; Robert W. Holloway; Manuel Rodrigues; Hye Sook Chon; Charlie Gourley; Alessandro D. Santin; Premal H. Thaker; Christine Gennigens; Gregg Newman; Erin Salinas; Hagop Youssoufian; Kathleen N. Moore; Stephanie Lustgarten; David M. O’Malley; Toon Van Gorp; Rachel N. Grisham

Rucaparib maintenance for newly diagnosed advanced ovarian cancer: interim overall survival, progression-free survival, and safety at 5 years of follow-up from the phase III ATHENA-MONO/GOG-3020/ENGOT-ov45 鲁卡帕利用于新诊断晚期卵巢癌的维持治疗：来自III期ATHENA-MONO/GOG-3020/ENGOT-ov45研究5年随访的 interim 总体生存期、无进展生存期及安全性数据

Annals of Oncology

IF65.4

2025-10-18

OAAI

R.S. Kristeleit; S. Ghamande; A. Lisyanskaya; A. Oaknin; E. Prendergast; Y.B. Kim; J.Fuentes Pradera; R.D. Littell; B. Gao; G. Valabrega; D.M. O’Malley; A. Dean; C. Pisano; J. Buscema; D. Provencher; F. Zagouri; L.P. Martin; H.-H. Chou; F. Demirkiran; F. Ueland; A. Chudecka-Głaz; O. Yeku; M. Beiner; C. Anderson; V. Drochytek; R.N. Eskander; R. Agarwal; L. Maloney; D. Despain; C. Connor; M. Craib; D. Shih; K. Fujiwara; B.J. Monk

Assessment of Probiotic and Prebiotic Use in Gynecologic Cancer Patients: A Systematic Review 益生菌和益生元在妇科癌症患者中的使用评估：一项系统综述

American Journal of Obstetrics and Gynecology

IF8.4

2025-10-08

PREAI

Julia Chalif; Molly Morton; Paulina Haight; Yogita Mehra; David O’Malley; Dan Spakowicz; Laura Chambers

The price of delay: Insurance-related treatment delays in patients with gynecologic cancer receiving immunotherapy 延迟的代价：接受免疫治疗的妇科癌症患者中与保险相关的治疗延迟

gynecologic oncology

IF4.1

2025-08-29

PREAI

Molly Morton; Julia Chalif; Jessica Sciuva; Jessica Fulton; Reed O'Connor; David Cohn; Casey Cosgrove; Larry J. Copeland; Floor Backes; David M. O'Malley; Christa Nagel; Laura M. Chambers

Prognostic and demographic patterns in serous tubal intraepithelial carcinoma: A National Cancer Database study 输卵管原位腺癌的预后和人口统计学模式：一项国家癌症数据库研究

gynecologic oncology

IF4.1

2025-08-18

PREAI

Wafa Khadraoui; Ashley S. Felix; Caitlin E. Meade; Julia Chalif; Monica Levine; David M. O'Malley; Laura M. Chambers

Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)–targeting antibody-drug conjugate (ADC), in combination with pembrolizumab in patients with platinum-resistant ovarian cancer mirvetuximab soravtansine（一种靶向叶酸受体α（FRα）的抗体偶联药物，ADC）与pembrolizumab联合治疗铂耐药性卵巢癌患者的安全性与有效性

gynecologic oncology

IF4.1

2025-07-22

PREAI

Ursula A. Matulonis; Ignace Vergote; Kathleen N. Moore; Lainie P. Martin; Cesar M. Castro; Lucy Gilbert; Yu Xia; Michael Method; James Stec; Michael J. Birrer; David M. O'Malley

The GOG Foundation and EVA/LACOG partnership: a collaborative strategic alliance for clinical trial execution GOG基金会和EVA/LACOG合作伙伴关系：一个用于临床 trial 执行的协作战略联盟

International Journal of Gynecological Cancer

IF4.7

2025-06-27

PREAI

Fernando Maluf; Robert L. Coleman; Angélica Nogueira-Rodrigues; Bradley J. Monk; Glauco Baiocchi; Kathleen N. Moore; Andréia Cristina de Melo; David M. O’Malley; Graziela Z. Dal Molin; Leslie M. Randall; Gonzalo Giornelli; Brian Slomovitz; René Pareja; Bhavana Pothuri; Ramez N. Eskander; Gustavo Werutsky; Thomas J. Herzog

Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial Rucaparib用于铂敏感、复发性卵巢癌的维持治疗：III期、随机、安慰剂对照ARIEL3试验的最终结果

European Journal of Cancer

IF7.1

2025-06-17

OAAI

Jonathan A. Ledermann; Amit M. Oza; Domenica Lorusso; Carol Aghajanian; Ana Oaknin; Andrew Dean; Nicoletta Colombo; Johanne I. Weberpals; Andrew R. Clamp; Giovanni Scambia; Alexandra Leary; Robert W. Holloway; Margarita Amenedo Gancedo; Peter C. Fong; Jeffrey C. Goh; David M. O’Malley; Deborah K. Armstrong; Susana Banerjee; Jesús García-Donas; Elizabeth M. Swisher; Robert L. Coleman

GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of treatment in patients with recurrent low grade serous ovarian cancer GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301：一项评估阿伏莫替尼联合达法他尼与研究者选择治疗方案相比，在复发性低级别浆液性卵巢癌患者中的随机III期试验

International Journal of Gynecological Cancer

IF4.7

2025-04-19

OAAI

Rachel Grisham; Bradley J. Monk; Els Van Nieuwenhuysen; Kathleen Nadine Moore; Michel Fabbro; David M. O’Malley; Ana Oaknin; Premal Thaker; Amit M. Oza; Nicoletta Colombo; David Gershenson; Carol A. Aghajanian; Chel Hun Choi; Yeh Chen Lee; Mansoor Raza Mirza; Robert L. Coleman; Lauren Cobb; Philipp Harter; Stephanie Lustgarten; Hagop Youssoufian; Susana Banerjee

An open-label randomized active-controlled phase II clinical study to assess the efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer (PROFECTA-II/GOG-3044)一项开放标签、随机、活性对照的II期临床研究，旨在评估afuresertib联合paclitaxel相对于paclitaxel单药在铂耐药性卵巢癌患者中的有效性和安全性（PROFECTA-II/GOG-3044）。

gynecologic oncology

IF4.1

2025-03-01

PREAI

Herzog, Thomas J.; Liao, John B.; Finkelstein, Karen; Willmott, Lyndsay; Duan, Wei; Moroney, John W.; Buscema, Joseph; Campbell-Simms, Katie; Yue, Yong; Zweizig, Susan; Liu, Juan; Wang, Xiaoyu; Zang, Rong-Yu; Yin, Rutie; O'Malley, David M.; Wu, Lingying

Pembrolizumab in microsatellite-instability-high and mismatch-repair-deficient advanced solid tumors: updated results of the KEYNOTE-158 trial 帕博利珠单抗在微卫星高度不稳定和错配修复缺陷型晚期实体瘤中的研究：KEYNOTE-158试验的更新结果

NATURE CANCER

IF28.5

2025-02-20

PREAI

Marabelle, Aurelien; O'Malley, David M.; Hendifar, Andrew E.; Ascierto, Paolo A.; Motola-Kuba, Daniel; Penel, Nicolas; Cassier, Philippe A.; Bariani, Giovanni; De Jesus-Acosta, Ana; Doi, Toshihiko; Longo, Federico; Miller, Wilson H.; Oh, Do-Youn; Gottfried, Maya; Yao, Lili; Jin, Fan; Gozman, Alexander; Maio, Michele

Pembrolizumab in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) and non-MSI-H/non-dMMR advanced endometrial cancer: Phase 2 KEYNOTE-158 study results 帕博利珠单抗在微卫星高度不稳定/错配修复缺陷（MSI-H/dMMR）和非微卫星高度不稳定/非错配修复缺陷（non-MSI-H/non-dMMR）晚期子宫内膜癌中的疗效：KEYNOTE-158研究II期结果

gynecologic oncology

IF4.1

2025-02-01

PREAI

O'Malley, David M.; Bariani, Giovani M.; Cassier, Philippe A.; Marabelle, Aurelien; Hansen, Aaron R.; Acosta, Ana De Jesus; Miller Jr, Wilson H.; Safra, Tamar; Italiano, Antoine; Mileshkin, Linda; Yao, Lili; Gozma, Alexander; Jin, Fan; Maio, Michele

Assessment of readability of gynecologic cancer clinical trials literature at National Cancer Institute-designated Comprehensive Cancer Centers 国立癌症研究院指定的综合癌症中心妇科肿瘤临床试验文献的可读性评估

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

IF4.7

2025-02-01

PREAI

Chalif, Julia; Khadraoui, Wafa; Hays, John L.; Copeland, Larry J.; Vargas, Roberto; O'Malley, David M.; Chambers, Laura M.

Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)多塔利单抗联合化疗在dMMR/MSI-H原发性晚期或复发性子宫内膜癌患者中的有效性和安全性：一项III期、随机、安慰剂对照试验（ENGOT-EN6-NSGO/GOG-3031/RUBY）。

gynecologic oncology

IF4.1

2025-01-01

PREAI

Powell, Matthew A.; Cibula, David; O'Malley, David M.; Boere, Ingrid; Shahin, Mark S.; Savarese, Antonella; Chase, Dana M.; Gilbert, Lucy; Black, Destin; Herrstedt, Jorn; Sharma, Sudarshan; Kommoss, Stefan; Gold, Michael A.; Thijs, Anna M.; Ring, Kari; Bolling, Magnus Frodin; Buscema, Joseph; Gill, Sarah E.; Nowicki, Paul; Nevadunsky, Nicole; Callahan, Michael; Willmott, Lyndsay; McCourt, Carolyn; Billingsley, Caroline; Ghamande, Sharad A.; He, Zangdong; Balas, Morad Marco; Stevens, Shadi; Fleming, Evelyn; Mirza, Mansoor Raza

Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ ENGOT-OV26/GOG-3012 trial 新诊断晚期卵巢癌患者的尼拉帕尼一线维持治疗: PRIMA/ ENGOT-OV26/GOG-3012试验的最终总生存期结果

ANNALS OF ONCOLOGY

IF65.4

2024-11-01

OAAI

Monk, B. J.; Barretina-Ginesta, M. P.; Pothuri, B.; Vergote, I.; Graybill, W.; Mirza, M. R.; Mccormicky, C. C.; Lorusso, D.; Moore, R. G.; Freyer, G.; O'Cearbhaill, R. E.; Heitz, F.; O'Malley, D. M.; Redondo, A.; Shahin, M. S.; Vulsteke, C.; Bradley, W. H.; Haslund, C. A.; Chase, D. M.; Pisano, C.; Holman, L. L.; Perez, M. J. Rubio; Disilvestro, P.; Gaba, L.; Herzog, T. J.; Bruchim, I.; Compton, N.; Shtessel, L.; Malinowska, I. A.; Gonzalez-Martin, A.

Obesity-induced extracellular vesicles proteins drive the endometrial cancer pathogenesis: therapeutic potential of HO-3867 and Metformin

ONCOGENE

IF7.3

2024-10-16

OAAI

Sakaue, Takahiko; Dorayappan, Kalpana Deepa Priya; Zingarelli, Roman; Khadraoui, Wafa; Anbalagan, Muralidharan; Wallbillich, John; Bognar, Balazs; Wanner, Ross; Cosgrove, Casey; Suarez, Adrian; Koga, Hironori; Maxwell, G. Larry; O'Malley, David M.; Cohn, David E.; Selvendiran, Karuppaiyah

Tucatinib and Trastuzumab for Patients With Previously Treated, HER2-Altered Solid Tumors (SGNTUC-019): A Phase 2 Basket Study

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-10-01

PREAI

Nakamura, Y.; Bekaii-Saab, T.; Hamilton, E.; Hayashi, H.; Mizuno, N.; Monk, B. J.; Nguyen, D.; Okines, A.; O'Malley, D. M.; Pohlmann, P. R.; Pothuri, B.; Reck, M.; Sudo, K.; Sunakawa, Y.; Takahashi, S.; Yu, E. Y.; Drees, A.; Tan, S.; Stinchcombe, T. E.

研究方向